# Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19

> **NCT04399746** · NA · COMPLETED · sponsor: **Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado** · enrollment: 30 (actual)

## Conditions studied

- COVID

## Interventions

- **DRUG:** Ivermectin
- **DRUG:** Azithromycin
- **DRUG:** Cholecalciferol

## Key facts

- **NCT ID:** NCT04399746
- **Lead sponsor:** Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-15
- **Primary completion:** 2020-05-20
- **Final completion:** 2020-06-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04399746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04399746, "Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04399746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*